<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T03:57:53Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/30963" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/30963</identifier><datestamp>2026-09-24T07:27:30Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Paré, Guillaume</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Le, Ann</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Medical Sciences</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2025-01-27T19:21:20Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2025-01-27T19:21:20Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2025</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/30963</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/10426</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Polygenic risk scores (PRS) are relatively novel tools for risk prediction, serving as a quantitative&#xd;
singular value which depicts a patient’s genetic disposition for a certain disease.&#xd;
Given that many current clinical risk predictors do not address heritability within their&#xd;
calculations, PRS are likely to improve prediction, especially in the case of complex diseases&#xd;
which are influenced by a combination of genetic, environmental and lifestyle factors.&#xd;
Altogether, PRS studies have been pursued for their abilities in trait detection, therapeutic&#xd;
intervention and disease protection, with much potential in personalized/precision medicine&#xd;
where each interpretation is unique and based on a patient’s genotype. However, despite&#xd;
the numerous advances over years, PRS have yet to reach the level where they can be&#xd;
implemented into standard clinical practices as originally intended. The goal is to develop&#xd;
PRS which are applicable to global populations, which has yet to be achieved due to the&#xd;
inconsistency and general skepticism regarding the method. Furthermore, PRS have yet to&#xd;
reach the upper threshold for risk prediction, as indicated by the heritability that remains&#xd;
unaccounted for with PRS calculations. Thus, this thesis addresses how PRS can inform&#xd;
and guide clinical decision-making for complex decisions with strong, genetic dispositions.&#xd;
It also presents novel approach to PRS aimed at mitigating some of its current limitations.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Doctor of Philosophy (PhD)</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="layabstract" lang="en_US">Many common diseases, like coronary artery disease (CAD) and diabetes, are influenced&#xd;
not only by lifestyle and environmental factors, but also by genetics. Therefore, incorporating&#xd;
genetic information into disease risk prediction for patients in clinical settings would be&#xd;
logical, especially since genetic data can be obtained early in life. One tool for quantifying&#xd;
risk based on genetics is the polygenic risk score (PRS). PRS assigns a numerical value&#xd;
based on an individual’s genetic profile, calculated by summing up risk variants in their&#xd;
DNA. The risk level corresponds to the variant’s association with the trait, as determined&#xd;
by genome-wide association studies (GWAS). PRS have become increasingly popular for&#xd;
guiding disease treatment and personalized medicine. However, there’s still work to be&#xd;
done to make PRS suitable for clinical use. Many methods have attempted to enhance&#xd;
the predictive ability of PRS, but there’s still room for improvement. This thesis introduces&#xd;
various applications for PRS, along with a novel prediction method that potentially&#xd;
addresses some limitations and explores the applications of PRS in common diseases.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">genetics, epidemiology, bioinformatics, polygenic risk scores</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">NOVEL STATISTICAL METHODS FOR POLYGENIC RISK SCORE GENERATION IN CARDIOVASCULAR DISEASES</dim:field>
   <dim:field mdschema="dc" element="title" qualifier="alternative" lang="en_US">POLYGENIC RISK SCORES FOR THE PREDICTION OF CARDIOVASCULAR DISEASES</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>